Case report: CD7-targeted autologous CAR-T therapy for the treatment of T-cell acute lymphoblastic leukemia undergoing allogeneic peripheral blood stem cell transplantation in the long-term follow-up
The results of this case study provide evidence for the long-term efficacy of CD7-targeted autologous CAR-T-cell therapy without requiring secondary allo-HSCT in patients with r/r T-ALL that have relapsed after previous allogeneic PBSCT.
Authors
- Ping‐Ping Sun (ORCID: https://orcid.org/0000-0002-2772-2631)
- Xing-Guang Wang
- Qianqian Li (ORCID: https://orcid.org/0000-0002-8974-9768)
- Peng Wang (ORCID: https://orcid.org/0000-0002-7419-8836)
- Rui Zhang (ORCID: https://orcid.org/0000-0003-4690-3945)
- Lianlian Li (ORCID: https://orcid.org/0009-0004-3291-3637)
- Yong Xia (ORCID: https://orcid.org/0009-0000-7338-1041)
Institutions
- Shandong University (CN)
- People's Hospital of Cangzhou (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-11-15
- DOI
- https://doi.org/10.3389/fimmu.2024.1469251
- Citations
- 2
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.57
Funders
- Hebei Provincial Health and Family Planning Commission